ArticleFrontiers in endocrinology2026
CCN1-induced senescence and dysfunction of umbilical cord blood endothelial colony-forming cells in the pathogenesis of preeclampsia.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Maternal vascular dysfunction and impaired placental angiogenesis are key features of preeclampsia (PE). Umbilical cord blood-derived endothelial colony-forming cells (CB-ECFCs) contribute to fetal endothelial repair and vascular network formation, but their phenotype in PE remains incompletely understood. Methods: We investigated whether the matricellular protein CCN1 is associated with CB-ECFC senescence and dysfunction. CB-ECFCs were isolated from pregnancies complicated by PE (n = 8) and healthy pregnancies (n = 9). Cellular senescence was assessed by SA-β-galactosidase staining, qPCR, and Western blotting of senescence-associated markers and senescence-associated secretory phenotype factors. Control-derived CB-ECFCs were exposed to recombinant CCN1, with or without the gamma-secretase inhibitor DAPT, and senescence-associated proteins, cleaved Notch1, the redox-responsive protein HO-1, the inflammatory factor TNF-α, and the DNA damage-response marker gamma-H2AX were examined. Results: PE-derived CB-ECFCs showed reduced colony yield, increased senescence-associated markers, and higher secreted and cell-associated CCN1 expression. Recombinant CCN1 increased senescence-associated markers, cleaved Notch1, HO-1, TNF-α, and γ-H2AX and impaired CB-ECFC metabolic activity, migration, and tube formation. DAPT attenuated selected molecular changes and partially restored tube formation but not wound closure. Discussion: These findings identify increased CCN1 as a feature of PE-derived CB-ECFCs and support an association between CCN1 exposure, Notch1 signaling, oxidative stress, and CB-ECFC senescence and dysfunction. The CCN1/Notch1 axis may represent a potential mechanism contributing to fetoplacental endothelial dysfunction in PE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.